This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Enhancing NeuroImaging Genetics through Meta-Analysis | |
|---|---|
| Title | Enhancing NeuroImaging Genetics through Meta-Analysis |
Enhancing NeuroImaging Genetics through Meta-Analysis Meta-analysis amplifies statistical power by aggregating results across studies, enabling detection of subtle genotype–phenotype associations in brain imaging. Integrating datasets from consortia such as the Human Connectome Project, ENIGMA, UK Biobank, ADNI, and UK Biobank Imaging Study poses opportunities and complexities spanning cohort management, informatics, and reproducibility. This article summarizes rationale, methods, and best practices for combining neuroimaging and genetic data at scale.
Meta-analysis synthesizes evidence from disparate studies to estimate effect sizes more precisely, a principle used by projects like ENIGMA and initiatives supported by the National Institutes of Health and the European Research Council. Large-scale efforts often interlink repositories such as dbGaP, UK Biobank, ADNI, Human Connectome Project, and networks coordinated through institutions like Stanford University, Harvard University, University of Oxford, Massachusetts General Hospital, and University College London. Cross-study approaches draw on computational platforms developed at centers including Broad Institute, Wellcome Trust Sanger Institute, and Max Planck Society.
Pooling studies addresses limited power in individual cohorts exemplified by early work at Columbia University and Johns Hopkins University where small samples constrained genome-wide association studies compared to landmark projects like 1000 Genomes Project, ENIGMA, and UK Biobank. Meta-analysis mitigates idiosyncratic cohort effects observed in datasets from Alzheimer's Disease Neuroimaging Initiative and multisite consortia coordinated by National Institute of Mental Health or funded through European Commission programs. Advantages include replication across populations enrolled at Mayo Clinic, Karolinska Institutet, University of Toronto, and University of Melbourne and harmonized inference that informs policy at organizations such as World Health Organization.
Design considerations mirror approaches used in multicenter trials at Cleveland Clinic, Mayo Clinic, and multicohort genetics studies like GIANT Consortium. Key elements include prespecified analysis plans following guidelines from CONSORT-like frameworks adapted by STROBE and recommendations by NIH working groups. Sampling strategies reference population genetics resources such as 1000 Genomes Project, HapMap Project, and haplotype maps produced at Wellcome Trust Sanger Institute. Study design must coordinate imaging protocols used at sites like Massachusetts General Hospital, University College London, and Vanderbilt University.
Harmonization draws on pipelines developed at ENIGMA, Human Connectome Project, and software from FMRIB at University of Oxford and Laboratory of Neuro Imaging at University of Southern California. Quality control practices reflect standards from repositories such as dbGaP, ADNI, and initiatives supported by National Institute on Aging. Steps include standardized preprocessing analogous to workflows at Stanford University and Johns Hopkins University, variant calling QC following protocols from Broad Institute and Wellcome Trust Sanger Institute, and phenotype curation as performed in studies at University of California, Los Angeles and University of Cambridge.
Meta-analytic models range from fixed-effects frameworks used in early genome-wide meta-analyses by the GIANT Consortium to random-effects models implemented in tools from the Broad Institute and statistical packages developed at R-project-affiliated groups. Software commonly employed includes pipelines originating from ENIGMA, utilities at FMRIB and FreeSurfer suites developed at Massachusetts General Hospital. Methods for multiple testing correction and polygenic scoring relate to work at Broad Institute, Wellcome Trust Sanger Institute, and consortia like Psychiatric Genomics Consortium.
Heterogeneity across scanners and protocols at sites such as Johns Hopkins University, University of California, San Diego, Karolinska Institutet, and Universidad Autónoma de Madrid produces site effects analogous to batch effects observed in genomic studies at Broad Institute. Population stratification issues documented in 1000 Genomes Project and HapMap Project complicate interpretation, while privacy and data sharing constraints intersect with regulations like those influenced by U.S. Department of Health and Human Services policy and ethics frameworks adopted at Harvard Medical School and ETH Zurich. Computational burden mirrors challenges faced by projects at European Bioinformatics Institute and National Center for Biotechnology Information.
Successes include discovery of imaging–genotype associations in aging cohorts coordinated by ADNI, psychiatric imaging genetics results from collaborations involving Psychiatric Genomics Consortium, and structural brain trait mapping performed by ENIGMA with contributions from University of Queensland and Utrecht University. Meta-analytic integration facilitated biomarker identification in studies affiliated with Mayo Clinic, Karolinska Institutet, University of Toronto, and pharmacogenomic interpretations linked to trials at National Institutes of Health Clinical Center.
Future progress depends on federated analysis frameworks inspired by work at European Bioinformatics Institute, increased interoperability via standards promulgated by FAIRsharing initiatives and governance models tested by Global Alliance for Genomics and Health. Best practices include preregistration akin to ClinicalTrials.gov, detailed data provenance used by Broad Institute workflows, and community standards developed by consortia such as ENIGMA and Psychiatric Genomics Consortium to ensure reproducibility across centers including Stanford University, Imperial College London, and Yale University.
Category:Neuroimaging Category:Genetics Category:Meta-analysis